Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly

Circulation Research

Volumn 90, Issue 3, 2002, Pages 251-262

  Galis, Zorina S ^a,b   Khatri, Jaikirshan J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine ^*  (United States)

Author keywords

Arterial remodeling; Atherosclerosis; Extracellular matrix; Metalloproteinases

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN 3;

ADAPTATION; ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL DIAMETER; CARDIOVASCULAR DISEASE; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME REGULATION; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; INFLAMMATION; INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; VASCULARIZATION;

EID: 0037155057     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/res.90.3.251     Document Type: Review

References (132)

1. The emerging concept of vascular remodeling
2. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure?
3. Proteolytic remodeling of extracellular matrix
4. Tissue inhibitors of metalloproteinases: Evolution, structure and function
5. Processing of tumour necrosis factor-α precursor by metalloproteinases
6. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1
7. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)
8. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3)
9. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor
10. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells: Effects of tumor necrosis factor α interleukin 1 and phorbol ester
11. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion
12. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
13. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue
14. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina
15. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis
16. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions
17. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
18. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: Relationship to lesion severity
19. Enhanced expression of matrix metalloproteinase-3, -12, and -13 mRNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis
20. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
21. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
22. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells
23. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques
24. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization
25. Hypercholesterolemia causes mechanical weakening of rabbit atheroma: Local collagen loss as a prerequisite of plaque rupture
26. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes
27. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms
28. Vascular extracellular matrix remodeling in cerebral aneurysms
29. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured smooth muscle cells
30. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts
31. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo
32. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro
33. Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury
34. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery
35. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat
36. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
37. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme
38. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
39. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes: A possible protective mechanism against atherothrombosis
40. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: New target for antioxidant therapy?
41. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model
42. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
43. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase
44. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory mediators
45. Inflammatory cytokines and oxidized-low density lipoproteins increase endothelial cell expression of membrane type-matrix metalloproteinase -1
46. Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model
47. Early effects of arterial hemodynamic conditions on human saphenous veins perfused ex vivo
48. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling
49. Endothelial dysfunction and collagen accumulation: Two independent factors for restenosis and constrictive remodeling after experimental angioplasty
50. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: Interaction with NO
51. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
52. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite
53. Cytokines regulate genes involved in atherosclerosis
54. Molecular mechanisms of plaque weakening and disruption
55. Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia
56. Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia
57. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages
58. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells
59. Perspectives series. Cell adhesion in vascular biology: Smooth muscle migration in atherosclerosis and restenosis
60. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo
61. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries
62. Atherosclerosis: An inflammatory disease
63. Endothelial dysfunction and the pathogenesis of atherosclerosis
64. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production
65. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent
66. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain
67. Extracellular matrix modulates macrophage functions characteristic to atheroma: Collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro
68. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
69. Metalloproteases in remodeling of vascular extracellular matrix
70. Structural and hemodynamic response of peripheral arteries of macaque monkeys to atherogenic diet
71. Compensatory enlargement of human atherosclerotic coronary arteries
72. Arterial remodeling: Relation to hemodynamics
73. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery
74. Matrix metalloproteinase-9 over-expression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery
75. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury
76. Angioscopic complex lesions are predominantly compensatory enlarged: An angioscopy and intracoronary ultrasound study
77. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study
78. Atherosclerotic plaque caps are locally weakened when macrophages density is increased
79. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
80. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
81. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: The remodeling paradox
82. Role of matrix metalloproteinases in abdominal aortic aneurysms
83. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases
84. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm
85. Size matters: The relationship between MMP-9 expression and aortic diameter
86. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model
87. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
88. Coronary plaque disruption
89. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly
90. Thrombosis and acute coronary artery lesions in sudden ischemic death
91. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: Implications for plaque rupture
92. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells
93. Release of gelatinase A during platelet activation mediates aggregation
94. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
95. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system
96. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries
97. The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system: A postmortem study
98. Serial volumetric intravascular ultrasound assessment of arterial remodeling in left main coronary artery disease
99. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy
100. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study
101. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy
102. Role of compensatory enlargement and shrinkage in transplant coronary artery disease: Serial intravascular ultrasound study
103. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model
104. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation
105. Mouse model of arterial injury
106. Wound healing: A paradigm for lumen narrowing after arterial reconstruction
107. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis
108. Collagen content is significantly lower in restenotic versus nonrestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model
109. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury
110. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation
111. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration
112. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
113. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration
114. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation
115. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis
116. Metalloproteinase blockade by local overexpression of TIMP-1 increases elastin accumulation in rat carotid artery intima
117. Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris
118. Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries
119. Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients
120. Molecular markers, fibrous cap rupture, and the vulnerable plaque: New experimental opportunities
121. Genetic diversity in the matrix metalloproteinase family: Effects on function and disease progression
122. Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis
123. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects
124. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis
125. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease
126. MMP inhibition following balloon angioplasty inhibits constrictive remodeling in favour of expansive enlargement: An intravascular ultrasound study
127. Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: A study in the atherosclerotic Yucatan micropig
128. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis
129. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
130. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins
131. Matrix metalloproteinase hypothesis of plaque rupture: Players keep piling up but questions remain
132. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse